How should I manage a patient with allergic rhinitis who reports that montelukast is no longer effective, is using intranasal azelastine, and continues to have rhinorrhea and occasional cough?

Discontinue montelukast and add an intranasal corticosteroid to the azelastine

The patient needs an intranasal corticosteroid (INCS) immediately—this is the most effective single agent for allergic rhinitis and should have been started before montelukast. Montelukast is significantly less effective than INCS and should be discontinued 1.

Why This Approach

Montelukast Is Inferior and Should Be Stopped

• Leukotriene antagonists like montelukast are clearly less potent than intranasal corticosteroids for controlling allergic rhinitis symptoms 2, 1
• Five trials consistently demonstrate that INCS provides clinically meaningful superior symptom reduction compared to montelukast 1
• The patient reporting that "montelukast is not working anymore" likely reflects its inherently limited efficacy rather than true treatment failure—it was never the right choice as monotherapy

The Optimal Regimen: INCS + Intranasal Antihistamine

Add an intranasal corticosteroid (fluticasone, mometasone, or similar) to the existing azelastine. This combination is specifically recommended by current guidelines:

• The combination of INCS and intranasal antihistamine is more effective than INCS alone for moderate-to-severe allergic rhinitis 2, 1
• This combination provides rapid symptom relief (within minutes from the antihistamine component) plus sustained control from the corticosteroid 2
• Real-world evidence shows the INCS + intranasal antihistamine combination significantly reduces both nasal symptoms (rhinorrhea, congestion) and improves quality of life 3

Specific Dosing Strategy

For the azelastine already being used:

• Continue azelastine 1-2 sprays per nostril twice daily 4

Add an INCS such as:

• Fluticasone propionate 200 mcg daily (2 sprays per nostril once daily) OR
• Mometasone furoate 200 mcg daily (2 sprays per nostril once daily)

Alternatively, consider a fixed-combination product (azelastine/fluticasone in a single spray device) which may improve adherence and has demonstrated superior efficacy to either component alone 5, 6.

Addressing the Specific Symptoms

Rhinorrhea (Runny Nose)

• INCS are highly effective for rhinorrhea control
• The combination with intranasal antihistamine provides additive benefit 7

Occasional Cough

• This likely represents postnasal drip from poorly controlled rhinitis
• INCS will reduce nasal secretions and inflammation, thereby reducing postnasal drainage
• If cough persists after 2 weeks of adequate rhinitis control, consider evaluating for concomitant asthma or other lower airway pathology

Critical Implementation Points

Proper Nasal Spray Technique

• Most treatment "failures" are actually technique failures
• Head tilted forward (looking at toes), not backward 4
• Aim spray laterally toward the ear, not straight back
• Alternate nostrils to avoid septal irritation

Timeline for Response

• Intranasal antihistamine: relief within minutes 2
• INCS: noticeable improvement within hours to days, maximum benefit at 1-2 weeks 2
• Reassess at 7-14 days; if inadequate response, verify technique before escalating therapy

Common Pitfalls to Avoid

1. Don't add an oral antihistamine to INCS—this combination offers no advantage over INCS alone 2
2. Don't continue montelukast—it adds minimal benefit and the patient has already demonstrated inadequate response
3. Don't assume the azelastine "isn't working"—it's likely being overwhelmed by inadequately treated inflammation; the INCS will address this

If This Regimen Fails

After 2 weeks of proper technique with INCS + intranasal antihistamine:

• Consider allergen immunotherapy referral 2
• Evaluate for anatomic obstruction (deviated septum, polyps)
• Reassess diagnosis (consider non-allergic rhinitis, chronic rhinosinusitis)